PETER D'ORSANEO: Open Payments
NPI 1093329872 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 89 payments from 13 companies in 2025. Trend: 2023 $32 · 2024 $266 · 2025 $1,883
Food & beverage: $1,883
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 31 | $609 |
| Gilead Sciences, Inc. | 25 | $582 |
| ABBVIE INC. | 14 | $273 |
| Theratechnologies Inc. | 5 | $101 |
| Amgen Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Hologic Sales and Service, LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $40 |
| Napo Pharmaceuticals Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: DOVATO, VRAYLAR, Biktarvy, MAVYRET, APRETUDE, EGRIFTA, RUKOBIA, REPATHA.
Industry payments across PA — which companies pay providers there.
